Literature DB >> 18054958

Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.

Ruodan Nan1, Jayesh Gor, Stephen J Perkins.   

Abstract

Factor H (FH) is a major regulator of complement alternative pathway activation. It is composed of 20 short complement regulator (SCR) domains and is genetically associated as a risk factor for age-related macular degeneration. Previous studies on FH suggested that it existed in monomeric and dimeric forms. Improved X-ray scattering and analytical ultracentrifugation methodology for wild-type FH permitted a clarification of these oligomeric properties. Data at lower concentrations revealed a dependence of the X-ray radius of gyration values on concentration that corresponded to the weak self-association of FH. Global sedimentation equilibrium fits indicated that a monomer-dimer equilibrium best described the data up to 1.3 mg/ml with a fitted dissociation constant K(D) of 28 microM and that higher oligomers formed at increased concentrations. The K(D) showed that about 85-95% of serum FH will be monomeric in the absence of other factors. Size-distribution analyses in sedimentation velocity experiments showed that monomeric FH was the major species but that as many as six oligomeric forms co-existed with it. The data were explained in terms of two weak dimerisation sites recently identified in the SCR-6/8 and SCR-16/20 fragments of FH with similar K(D) values. These observations indicate a mechanism for the progressive self-association of FH and may be relevant for complement regulation and the formation of drusen deposits that are associated with age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054958     DOI: 10.1016/j.jmb.2007.11.015

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights.

Authors:  Stephen J Perkins; Azubuike I Okemefuna; Ruodan Nan; Keying Li; Alexandra Bonner
Journal:  J R Soc Interface       Date:  2009-07-15       Impact factor: 4.118

Review 3.  Genetics and complement in atypical HUS.

Authors:  David Kavanagh; Tim Goodship
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

4.  Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.

Authors:  Azubuike I Okemefuna; Ruodan Nan; Ami Miller; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

5.  Polyanion-induced self-association of complement factor H.

Authors:  Michael K Pangburn; Nenoo Rawal; Claudio Cortes; M Nurul Alam; Viviana P Ferreira; Mark A L Atkinson
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 6.  Complement factor H: using atomic resolution structure to illuminate disease mechanisms.

Authors:  Paul N Barlow; Gregory S Hageman; Susan M Lea
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration.

Authors:  Ruodan Nan; Irene Farabella; Felix F Schumacher; Ami Miller; Jayesh Gor; Andrew C R Martin; David T Jones; Imre Lengyel; Stephen J Perkins
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

8.  Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.

Authors:  Jonathan P Hannan; Jennifer Laskowski; Joshua M Thurman; Gregory S Hageman; V Michael Holers
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

9.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 10.  Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands.

Authors:  Stephen J Perkins; Ka Wai Fung; Sanaullah Khan
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.